Correlation Between Highwealth Construction and BRIM Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Highwealth Construction and BRIM Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Highwealth Construction and BRIM Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Highwealth Construction Corp and BRIM Biotechnology, you can compare the effects of market volatilities on Highwealth Construction and BRIM Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Highwealth Construction with a short position of BRIM Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Highwealth Construction and BRIM Biotechnology.

Diversification Opportunities for Highwealth Construction and BRIM Biotechnology

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Highwealth and BRIM is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Highwealth Construction Corp and BRIM Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BRIM Biotechnology and Highwealth Construction is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Highwealth Construction Corp are associated (or correlated) with BRIM Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BRIM Biotechnology has no effect on the direction of Highwealth Construction i.e., Highwealth Construction and BRIM Biotechnology go up and down completely randomly.

Pair Corralation between Highwealth Construction and BRIM Biotechnology

Assuming the 90 days trading horizon Highwealth Construction Corp is expected to generate 0.87 times more return on investment than BRIM Biotechnology. However, Highwealth Construction Corp is 1.15 times less risky than BRIM Biotechnology. It trades about 0.17 of its potential returns per unit of risk. BRIM Biotechnology is currently generating about -0.25 per unit of risk. If you would invest  4,310  in Highwealth Construction Corp on September 18, 2024 and sell it today you would earn a total of  300.00  from holding Highwealth Construction Corp or generate 6.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Highwealth Construction Corp  vs.  BRIM Biotechnology

 Performance 
       Timeline  
Highwealth Construction 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Highwealth Construction Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
BRIM Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BRIM Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Highwealth Construction and BRIM Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Highwealth Construction and BRIM Biotechnology

The main advantage of trading using opposite Highwealth Construction and BRIM Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Highwealth Construction position performs unexpectedly, BRIM Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BRIM Biotechnology will offset losses from the drop in BRIM Biotechnology's long position.
The idea behind Highwealth Construction Corp and BRIM Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments